T. Rowe Price Associates »

Ascendis Pharma AS shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $350M 1.5M 228.73

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Ascendis Pharma AS

T. Rowe Price Associates
Principal Financial Group
Pictet Asset Management Holding SA
A.R. Schmeidler & Co
New York State Common Retirement Fund
Stacey Braun Associates
Walleye Trading Advisors
Driehaus Capital Management
TD Asset Management
Q Global Advisors
Sapient Capital
Walleye Trading
Tudor Investment Corporation
Standard Life Aberdeen
Handelsbanken Fonder AB

View all funds holding Ascendis Pharma AS